NPPM
GILD icon

North Point Portfolio Managers’s Gilead Sciences GILD Stock Holding History

North Point Portfolio Managers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-155,920
Closed -$10.1M – 68
2019
Q4 		$10.1M Sell
155,920
-2,649
-2% -$173K 1.73% 34
2019
Q3 		$10.1M Sell
158,569
-5,415
-3% -$354K 1.84% 33
2019
Q2 		$11.1M Sell
163,984
-718
-0.4% -$47.2K 2.03% 28
2019
Q1 		$10.7M Buy
164,702
+6,474
+4% +$430K 2.03% 27
2018
Q4 		$9.9M Sell
158,228
-11,609
-7% -$811K 2.19% 22
2018
Q3 		$13.1M Sell
169,837
-3,806
-2% -$287K 2.23% 22
2018
Q2 		$12.3M Sell
173,643
-5,991
-3% -$423K 2.12% 27
2018
Q1 		$13.5M Sell
179,634
-4,523
-2% -$360K 2.32% 24
2017
Q4 		$13.2M Sell
184,157
-18,248
-9% -$1.39M 2.23% 25
2017
Q3 		$16.4M Sell
202,405
-2,480
-1% -$190K 2.77% 11
2017
Q2 		$14.5M Sell
204,885
-1,575
-0.8% -$105K 2.53% 20
2017
Q1 		$14M Sell
206,460
-2,565
-1% -$180K 2.52% 16
2016
Q4 		$15M Sell
209,025
-4,278
-2% -$318K 2.83% 10
2016
Q3 		$16.9M Sell
213,303
-122
-0.1% -$9.91K 3.22% 7
2016
Q2 		$17.8M Sell
213,425
-4,657
-2% -$413K 3.5% 5
2016
Q1 		$20M Sell
218,082
-3,665
-2% -$331K 3.85% 2
2015
Q4 		$22.4M Sell
221,747
-2,980
-1% -$310K 4.33% 1
2015
Q3 		$22.1M Sell
224,727
-1,097
-0.5% -$122K 4.4% 1
2015
Q2 		$26.4M Sell
225,824
-252
-0.1% -$27.5K 4.82% 1
2015
Q1 		$22.2M Buy
226,076
+3,669
+2% +$373K 4.11% 2
2014
Q4 		$21M Buy
222,407
+3,500
+2% +$362K 4% 3
2014
Q3 		$23.3M Sell
218,907
-31,115
-12% -$3.05M 4.67% 1
2014
Q2 		$20.7M Buy
250,022
+1,069
+0.4% +$83.2K 4.17% 1
2014
Q1 		$17.6M Buy
248,953
+3,850
+2% +$302K 3.74% 2
2013
Q4 		$18.4M Buy
245,103
+376
+0.2% +$26.2K 3.92% 1
2013
Q3 		$15.4M Sell
244,727
-2,833
-1% -$169K 3.63% 3
2013
Q2 		$12.7M Buy
+247,560
New +$12.9M 3.19% 6

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

North Point Portfolio Managers's GILD Position: Q1 2020 in Review

North Point Portfolio Managers sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 155,920 shares — an estimated $10.1M sold.

North Point Portfolio Managers first reported a position in GILD in Q2 2013 and held it in 27 quarters. The position peaked at $26.4M in Q2 2015. 1,642 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • North Point Portfolio Managers reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • North Point Portfolio Managers sold 155,920 Gilead Sciences shares in Q1 2020, an estimated $10.1M.
  • North Point Portfolio Managers first reported a position in Gilead Sciences in Q2 2013 and held it in 27 quarters.
  • North Point Portfolio Managers's Gilead Sciences position peaked at $26.4M in Q2 2015.
  • 1,642 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on North Point Portfolio Managers's 13F filing for Q1 2020, filed 28 Apr 2020.